BarbaraRubinoMD

Psychiatry • Los Angeles, CA

Addiction

Physician

Join to view full profile

Dr. Rubino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rubino's full profile

Already have an account?

Office
2020 Zonal Ave
Ird Building 6TH floor
Los Angeles, CA 90089
Phone+1 323-226-7953

Fax+1 323-226-2899

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2012 - 2015
Keck School of Medicine of the University of Southern CaliforniaClass of 2012

Certifications & Licensure

CA State Medical License 2013 - 2025
FL State Medical License 2020 - 2025
GA State Medical License 2021 - 2025
TX State Medical License 2021 - 2025
CT State Medical License 2022 - 2024
NY State Medical License 2021 - 2024
TN State Medical License 2021 - 2024
CO State Medical License 2020 - 2023
MI State Medical License 2015 - 2016
American Board of Internal Medicine Internal Medicine
Join now to see all

Clinical Trials

Evaluation of Prevent in Underserved Populations Start of enrollment: 2016 Jan 01
Completed
Not Applicable

Publications & Presentations

PubMed

26 citations
In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
Trevor E. Angell, Carole A. Spencer, Barbara D Rubino, John T. Nicoloff, Jonathan S. LoPresti
Thyroid. 2014-07-03
30 citations
Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
H. Max Bruins, Ryan P. Dorin, Barbara Rubino, Gus Miranda, Jie Cai
European Urology. 2012-10-01
29 citations
Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.
Radu O. Minea, Corey M. Helchowski, Barbara Rubino, Kyle Brodmann, Stephen Swenson
Toxicon. 2012-03-15

Press Mentions

Why L.A.'s Largest County Hospital Is Asking Patients About Way More Than Their SymptomsMarch 22nd, 2018
With Patients in Need of More Than Medicine, LA’s Biggest Safety Net Hospital Overhauls Primary CareMarch 20th, 2018
A Simple Test Is Helping Thousands of Diabetics in L.A. County Who Face an Increased Risk of Going BlindJune 12th, 2017